Basis for loss of therapeutic effectiveness of L-asparaginase in sensitized mice.
D000818:Animals; D000917:Antibody Formation; D001215:Asparaginase / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D004926:Escherichia coli / Q000201:enzymology; D006207:Half-Life; D007114:Immunization; D007275:Injections, Intravenous; D007700:Kinetics; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013997:Time Factors
D001215:Asparaginase